Literature DB >> 9642131

Expression of the BCL6 gene in the pre- and postnatal mouse.

S Bajalica-Lagercrantz1, F Piehl, F Farnebo, C Larsson, J Lagercrantz.   

Abstract

Human BCL6, also called LAZ3, is a protein involved in gene regulation and abnormal expression of BCL6 and has been implicated in the tumorigenesis of non-Hodgkin lymphoma. We have analyzed the expression of murin bcl6 in pre- and postnatal mouse using in situ hybridization histochemistry and Northern blotting. The developing olfactory epithelium in the nasal cavity was the only tissue displaying a positive bcl6 mRNA signal in the day 14 embryo. At gestational day 17, expression was primarily seen in skeletal muscle, olfactory epithelium, and thymus, and also in the epithelium lining the upper airways and esophagus. In selected tissues from postnatal mouse, bcl6 expression was detected in brain, renal cortex, spleen, and thymus. The expression in brain was restricted to the pyramidal cell layer of the cerebral cortex and the hippocampus regions CA1 and CA2, and the dentate gyrus. Our results show that bcl6 expression is not confined only to organs of the lymphatic system, such as spleen and thymus. Thus, bcl6 may be active as a regulator of gene transcription in many different cell types, including epithelial and nerve cells. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9642131     DOI: 10.1006/bbrc.1998.8551

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling.

Authors:  Avi Shvarts; Thijn R Brummelkamp; Ferenc Scheeren; Eugene Koh; George Q Daley; Hergen Spits; René Bernards
Journal:  Genes Dev       Date:  2002-03-15       Impact factor: 11.361

2.  Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas.

Authors:  Xing Wang; Zhiping Li; Akira Naganuma; B Hilda Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-29       Impact factor: 11.205

3.  BCOR mutations and unstoppable root growth: a commentary on oculofaciocardiodental syndrome: novel BCOR mutations and expression in dental cells.

Authors:  Piranit Nik Kantaputra
Journal:  J Hum Genet       Date:  2014-05-01       Impact factor: 3.172

4.  The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases.

Authors:  Beverly W Baron; Rebecca M Baron; Joseph M Baron
Journal:  Biochim Biophys Acta       Date:  2014-12-31

5.  BCoR, a novel corepressor involved in BCL-6 repression.

Authors:  K D Huynh; W Fischle; E Verdin; V J Bardwell
Journal:  Genes Dev       Date:  2000-07-15       Impact factor: 11.361

6.  MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis.

Authors:  Zheng-Sheng Wu; Qiang Wu; Chao-Qun Wang; Xiao-Nan Wang; Yan Wang; Jing-Jing Zhao; Shan-Shan Mao; Gui-Hong Zhang; Nong Zhang; Xiao-Chun Xu
Journal:  BMC Cancer       Date:  2010-10-09       Impact factor: 4.430

7.  B-cell lymphoma 6 promotes proliferation and survival of trophoblastic cells.

Authors:  Cornelia Muschol-Steinmetz; Britta Jasmer; Nina-Naomi Kreis; Kerstin Steinhäuser; Andreas Ritter; Udo Rolle; Juping Yuan; Frank Louwen
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

8.  Bcl6a function is required during optic cup formation to prevent p53-dependent apoptosis and colobomata.

Authors:  Jiwoon Lee; Bum-Kyu Lee; Jeffrey M Gross
Journal:  Hum Mol Genet       Date:  2013-05-12       Impact factor: 6.150

9.  Male-specific hepatic Bcl6: growth hormone-induced block of transcription elongation in females and binding to target genes inversely coordinated with STAT5.

Authors:  Rosana D Meyer; Ekaterina V Laz; Ting Su; David J Waxman
Journal:  Mol Endocrinol       Date:  2009-10-01

10.  MicroRNA-187 induces diffuse large B-cell lymphoma cell apoptosis via targeting BCL6.

Authors:  Fang Huang; Yaofeng Jin; Yafeng Wei
Journal:  Oncol Lett       Date:  2016-03-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.